Product Information

DRIZALMA SPRINKLE DR 40 MG CAP is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $7.2212 per EA under NDC 47335061830. Its NADAC has been published 58 times since Mar 19, 2025.

FDA first approved this application on Jul 19, 2019.

The High Outlier badge above means this manufacturer's average price in the Duloxetine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DRIZALMA SPRINKLE DR 40 MG CAP

Duloxetine
$7.2212per EA
High Outlier

Strength

40 mg/1

NDC

47335061830

Classification

Brand

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DULOXETINE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA212516

FDA Approved

7/19/2019

On Market Since

6/10/2024

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for DRIZALMA SPRINKLE DR 40 MG CAP has been published 58 times since Mar 19, 2025, and over the history we have for it it has risen 10.9%. The table below summarizes its recorded NADAC range and movement.

Current price$7.2212 per EA
All-time high$7.2212 (Aug 19, 2026)
All-time low$6.5128 (Mar 19, 2025)
52-week high$7.2212
52-week low$7.1607
Median price$7.1607
Average price$7.1282
Largest weekly change+9.9% (Apr 9, 2025)
Weeks tracked58
Tracking sinceMar 19, 2025

Price History

1W

+0.8%

1M

+0.8%

3M

+0.8%

6M

+0.8%

1Y

+0.8%

3Y

N/A

5Y

N/A

All

+10.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 81% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DRIZALMA SPRINKLE DR 40 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DRIZALMA SPRINKLE DR 40 MG CAP, manufactured by Sun Pharmaceutical Industries Inc., is $7.2212 per EA (NDC 47335061830), effective Aug 19, 2026.

How has the price of DRIZALMA SPRINKLE DR 40 MG CAP changed over time?

Over the history we have for it, the NADAC for DRIZALMA SPRINKLE DR 40 MG CAP has risen 10.9%. It has been tracked across 58 weekly CMS publications since Mar 19, 2025.

What are the highest and lowest recorded NADAC prices for DRIZALMA SPRINKLE DR 40 MG CAP?

Since Mar 19, 2025, the NADAC for DRIZALMA SPRINKLE DR 40 MG CAP has ranged from a low of $6.5128 (Mar 19, 2025) to a high of $7.2212 (Aug 19, 2026), with a median of $7.1607 per EA.

Are there cheaper alternatives to DRIZALMA SPRINKLE DR 40 MG CAP?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DULOXETINE HCL DR 40 MG CAP, is $1.3767 per EA — about 81% below DRIZALMA SPRINKLE DR 40 MG CAP.

Who manufactures DRIZALMA SPRINKLE DR 40 MG CAP?

DRIZALMA SPRINKLE DR 40 MG CAP (NDC 47335061830) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.